New Google TurboQuant algorithm improves vector search speed

A small error-correction signal keeps compressed vectors accurate, enabling broader, more precise AI retrieval.
InfoQ

Java 26 Delivers Language Innovation, Library Improvements, Performance and Security

Oracle has released version 26 of the Java programming language and virtual machine. As the first non-LTS release since JDK ...

Java 26 with JVM optimizations, HTTP/3, and finally no Applet API

The current OpenJDK 26 is strategically important and not only brings exciting innovations but also eliminates legacy issues like the outdated Applet API.
Morningstar

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS ~ Designation enables an enhanced development ...
Business Wire

Dyno Therapeutics Unveils Best-in-Class Dyno-bn8 AAV Vector for Muscle Gene Therapies, Achieving Therapeutic Delivery With Improved Safety Potential

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, announced ...
InfoWorld

Enter the parallel universe of Java’s Vector API

The Vector API gives Java developers everything they need to tap into CPU-level performance gains for numerically intensive operations. If there is one thing you can describe as an obsession for both ...
TMCnet

Oracle Releases Java 24

AUSTIN, Texas, March 18, 2025 /PRNewswire/ -- Oracle today announced the availability of Java 24, the latest version of the world's number one programming language and development platform. Java 24 ...
BioSpace

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

Oxford, UK – 20 February 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that its proprietary lentiviral vector manufacturing technology will be ...